Raymond Rubin, MD
Transplant Hepatology · Atlanta, GANPI 1033113691
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $37,510 of the $61,138 with a category attached, or 61.4%. 16 manufacturers reported payments, led by Mallinckrodt Hospital Products Inc. at 55.1% of the total. Reporting peaked in 2022 at $17,017 and has fallen 99.7% since, to $45 in 2025.
Across 73 payments — averaging $837.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mallinckrodt Hospital Products Inc.$34K
- Intercept Pharmaceuticals, Inc.$13K
- Mallinckrodt Enterprises LLC$8K
- Wilson Cook Medical Incorporated$6K
- Boston Scientific$467
- Gilead$159
- plus $588 from 10 others
Across 369 payments — averaging $4485.53 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Modernatx, Inc.$808K
- Intercept Pharmaceuticals, Inc.$303K
- Gilead$198K
- Mallinckrodt Enterprises LLC$100K
- AbbVie$87K
- Novo Nordisk AS$79K
- plus $80K from 3 others
What the payments were for
- Consulting fees$19,01531%
- Speaking & faculty fees$37,51061%
- Travel & lodging$2,3614%
- Food & beverage$2,2014%
- Education$520%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mallinckrodt Hospital Products Inc. | 15 | $33,712 |
| Intercept Pharmaceuticals, Inc. | 19 | $12,740 |
| Mallinckrodt Enterprises LLC | 6 | $7,973 |
| Wilson Cook Medical Incorporated | 2 | $5,500 |
| Boston Scientific | 3 | $467 |
| Gilead | 8 | $159 |
| TELA Bio, Inc. | 1 | $149 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $120 |
| Astellas Pharma US Inc | 5 | $100 |
| Intra-sana Laboratories | 1 | $52 |
| Baxter Healthcare | 1 | $42 |
| Bayer | 2 | $37 |
| AbbVie | 1 | $24 |
| Madrigal Pharmaceuticals | 1 | $22 |
| AstraZeneca | 1 | $21 |
| Ipsen Biopharmaceuticals, Inc | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TERLIVAZ$21,176
- EchoTip$5,500
- OCALIVA$873
- GENERAL - THERAPIES$169
- TheraSphere Y90 Glass Microspheres 10 GBq$152
- Ovitex$149
- GENERAL VASCULAR INTERVENTION$145
How this compares
Too few transplant hepatology providers in Georgiato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other transplant hepatology in Atlanta
- Lance SteinAtlanta$941K
- Devina BhasinAtlanta$26K
- Giorgio RoccaroAtlanta$13K
- Alexander LemmerAtlanta$6K
- Shivani ShahAtlanta$1K
- Ravi VoraAtlanta$542
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.